×
Familial and Individual Correlates of Nonsuicidal Self-Injury in the Offspring of Mood-Disordered Parents PDF
$ 40.00
Familial and Individual Correlates of Nonsuicidal Self-Injury in the Offspring of Mood-Disordered Parents PDF quantity
$ 40.00
×
The Efficacy and Safety of a New Enteric-Coated Formulation of Fluoxetine Given Once Weekly During the Continuation Treatment of Major Depressive Disorder PDF
$ 40.00
The Efficacy and Safety of a New Enteric-Coated Formulation of Fluoxetine Given Once Weekly During the Continuation Treatment of Major Depressive Disorder PDF quantity
$ 40.00
×
Does the Presence of One Feature of Borderline Personality Disorder Have Clinical Significance? Implications for Dimensional Ratings of Personality Disorders PDF
$ 40.00
Does the Presence of One Feature of Borderline Personality Disorder Have Clinical Significance? Implications for Dimensional Ratings of Personality Disorders PDF quantity
$ 40.00
×
Effects of Escitalopram Prophylaxis During Antiviral Treatment for Chronic Hepatitis C in Patients With a History of Intravenous Drug Use and Depression PDF
$ 40.00
Effects of Escitalopram Prophylaxis During Antiviral Treatment for Chronic Hepatitis C in Patients With a History of Intravenous Drug Use and Depression PDF quantity
$ 40.00
×
A Comparison of Nefazodone and Fluoxetine on Mood and on Objective, Subjective, and Clinician-Rated Measures of Sleep in Depressed Patients: A Double-Blind, 8-Week Clinical Trial PDF
$ 40.00
A Comparison of Nefazodone and Fluoxetine on Mood and on Objective, Subjective, and Clinician-Rated Measures of Sleep in Depressed Patients: A Double-Blind, 8-Week Clinical Trial PDF quantity
$ 40.00
×
Prevalence of Metabolic Syndrome and Associated Factors in a Cohort of Individuals With Treatment-Resistant Depression: Results From the FACE-DR Study PDF
$ 40.00
Prevalence of Metabolic Syndrome and Associated Factors in a Cohort of Individuals With Treatment-Resistant Depression: Results From the FACE-DR Study PDF quantity
$ 40.00
×
Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone PDF
$ 40.00
Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart